文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Evaluation of CO laser efficacy in the treatment of cutaneous leishmaniasis.

作者信息

Asilian A, Sharif A, Faghihi G, Enshaeieh Sh, Shariati F, Siadat A H

机构信息

Department of Dermatology, Leishmaniasis Research Center, Isfahan University School of Medicine, XXX Iran.

出版信息

Int J Dermatol. 2004 Oct;43(10):736-8. doi: 10.1111/j.1365-4632.2004.02349.x.


DOI:10.1111/j.1365-4632.2004.02349.x
PMID:15485530
Abstract

BACKGROUND: Cutaneous leishmaniasis is a common disease in Iran, especially in the north-east, central and southern parts of the country. Many treatments have been suggested for this disease but none is completely effective and without side-effects such as pain, arthralgia and renal or cardiac complications. Lasers have been used for treatment of several skin diseases since 1970, and CO(2) lasers are now being used for treatment of leishmaniasis. In this study, a CO(2) laser (Sonic 500 machine) was used as a source of a continuous CO(2) laser wave. METHODS: A total of 123 patients (68 female and 55 male) with 183 lesions were treated with the CO(2) laser. The maximum power was 100 W and the pulse width was 0.5-5 s. For the control group, 110 patients (with 250 lesions) were treated with glucantime 50 mg/kg/day for 15 days and, after 15 days of rest, this treatment was repeated (Glucantime Amps, 1.5 g in a 50-mL solution, was used). For follow-up, the patients were visited 1, 3, 4, 8, 12 and 24 weeks after treatment and any complications, recurrences or other wound characteristics were recorded. In the second group, Finally, all collected data were analyzed statistically. RESULTS: Statistical analysis with the chi(2) test showed that treatment with the CO(2) laser was more effective than treatment with glucantime (P = 0.0007). Complications were also seen less often with the laser treatment than with glucantime and were limited to the ulcer site. The CO(2) laser was more effective in treating cutaneous leishmaniasis than glucantime (1.12 times), had fewer side-effects (4.5% vs. 24%) and resulted in a shorter healing time (1 month vs. 3 months), and treatment could be applied in a single session. CONCLUSIONS: The results of this and previous studies suggest that cutaneous leishmaniasis can be treated effectively with CO(2) laser if those providing the treatment are sufficiently experienced. Laser treatment is more cost-effective than other treatments and can be used as first-line therapy for cutaneous leishmaniasis (wet and dry types).

摘要

相似文献

[1]
Evaluation of CO laser efficacy in the treatment of cutaneous leishmaniasis.

Int J Dermatol. 2004-10

[2]
A comparative study between the efficacy of systemic meglumine antimoniate therapy with standard or low dose plus oral omeprazole in the treatment of cutaneous leishmaniasis.

J Vector Borne Dis. 2008-12

[3]
Effect of combination therapy with systemic glucantime and pentoxifylline in the treatment of cutaneous leishmaniasis.

Int J Dermatol. 2006-7

[4]
Effect of topical honey application along with intralesional injection of glucantime in the treatment of cutaneous leishmaniasis.

BMC Complement Altern Med. 2007-4-27

[5]
Comparative study of the efficacy of oral ketoconazole with intra-lesional meglumine antimoniate (Glucantime) for the treatment of cutaneous leishmaniasis.

J Dermatolog Treat. 2001-9

[6]
Efficacy of CO(2) laser for treatment of anthroponotic cutaneous leishmaniasis, compared with combination of cryotherapy and intralesional meglumine antimoniate.

J Eur Acad Dermatol Venereol. 2011-5

[7]
Efficacy of azithromycin versus systemic meglumine antimoniate (Glucantime) in the treatment of cutaneous leishmaniasis.

Am J Trop Med Hyg. 2007-7

[8]
Comparison of meglumine antimoniate and pentamidine for peruvian cutaneous leishmaniasis.

Am J Trop Med Hyg. 2005-2

[9]
Efficacy of glucantime in the treatment of Old World cutaneous leishmaniasis.

Int J Dermatol. 2009-7

[10]
Comparison of Thymus vulgaris (Thyme), Achillea millefolium (Yarrow) and propolis hydroalcoholic extracts versus systemic glucantime in the treatment of cutaneous leishmaniasis in balb/c mice.

J Vector Borne Dis. 2008-12

引用本文的文献

[1]
Effectiveness of carbon dioxide cryotherapy for the treatment of cutaneous leishmaniasis: Systematic review and meta-analysis.

PLoS Negl Trop Dis. 2025-1-6

[2]
Effect of Intralesional Sodium Stibogluconate Alone versus Combinations with Topical Trichloroacetic Acid 50% or Fractional Carbon Dioxide Laser on Cutaneous Leishmaniasis.

Indian J Dermatol. 2023

[3]
Treatment of Cutaneous Leishmaniasis with Intense Pulsed Light: Is it Effective?

Adv Biomed Res. 2023-5-15

[4]
Alternative Non-Drug Treatment Options of the Most Neglected Parasitic Disease Cutaneous Leishmaniasis: A Narrative Review.

Trop Med Infect Dis. 2023-5-14

[5]
Heat therapy for cutaneous leishmaniasis: A literature Review.

J Res Med Sci. 2021-2-27

[6]
Evaluation of the Interventional Approaches in the Management of Cutaneous Leishmaniasis in Jazan: An Observational Study.

Ann Dermatol. 2018-10

[7]
The effect of Nd:YAG laser therapy on cutaneous leishmaniasis compared to intralesional meglumine antimoniate.

Postepy Dermatol Alergol. 2019-4

[8]
Interventions for Old World cutaneous leishmaniasis.

Cochrane Database Syst Rev. 2017-12-1

[9]
Interventions for Old World cutaneous leishmaniasis.

Cochrane Database Syst Rev. 2017-11-17

[10]
A Comparison between the Effects of Glucantime, Topical Trichloroacetic Acid 50% plus Glucantime, and Fractional Carbon Dioxide Laser plus Glucantime on Cutaneous Leishmaniasis Lesions.

Dermatol Res Pract. 2016

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索